Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Osteomyelofibrose ist eine Knochemarkerkrankung bei der es zu einer übermäßigen Fibrosierung des Knochenmarkes kommt. Das Knochenmark wird von fibrotischem Narbengewebe verdrängt. Die Erkrankung kann durch somatische Mutationen im JAK2-Gen hervorgerufen werden.
| 1. |
Baxter EJ et al. () Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. [^] |
| 2. |
Kralovics R et al. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. [^] |
| 3. |
Méndez-Ferrer S et al. (2008) Haematopoietic stem cell release is regulated by circadian oscillations. [^] |
| 4. |
Méndez-Ferrer S et al. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. [^] |
| 5. |
Arranz L et al. (2014) Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. [^] |
| 6. |
Delhommeau F et al. (2009) Mutation in TET2 in myeloid cancers. [^] |
| 7. |
Sieff CA et al. (1980) Familial myelofibrosis. [^] |
| 8. |
Bonduel M et al. (1998) Familial idiopathic myelofibrosis and multiple hemangiomas. [^] |
| 9. |
Pikman Y et al. (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. [^] |
| 10. |
Pardanani AD et al. (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. [^] |
| 11. |
Kaufmann KB et al. (2012) A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2. [^] |
| 12. |
Jutzi JS et al. (2013) MPN patients harbor recurrent truncating mutations in transcription factor NF-E2. [^] |
| 13. |
Cazzola M et al. (2014) JAK inhibitor in CALR-mutant myelofibrosis. [^] |
| 14. |
Passamonti F et al. (2014) JAK inhibitor in CALR-mutant myelofibrosis. [^] |
| 15. |
Cassinat B et al. (2014) Interferon alfa therapy in CALR-mutated essential thrombocythemia. [^] |
| 16. |
Orphanet article Orphanet ID 824 [^] |
| 17. |
OMIM.ORG article Omim 254450 [^] |
| 18. |
Wikipedia Artikel Wikipedia DE (Osteomyelofibrose) [^] |
 |
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944 Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz |
